The autonomic nervous system and some aspects of the use of autonomic drugs in children. II.
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D001024:Aortic Valve Stenosis / Q000188:drug therapy; D001249:Asthma / Q000188:drug therapy; D001337:Autonomic Agents / Q000627:therapeutic use*; D001991:Bronchitis / Q000188:drug therapy; D002312:Cardiomyopathy, Hypertrophic / Q000188:drug therapy; D002648:Child; D002675:Child, Preschool; D003490:Cyanosis / Q000188:drug therapy; D003922:Diabetes Mellitus, Type 1 / Q000188:drug therapy; D004837:Epinephrine / Q000627:therapeutic use; D005260:Female; D006330:Heart Defects, Congenital / Q000188:drug therapy; D006801:Humans; D006973:Hypertension / Q000188:drug therapy; D007223:Infant; D007545:Isoproterenol / Q000627:therapeutic use; D008297:Male; D008781:Methyltyrosines / Q000627:therapeutic use; D010372:Pediatrics; D010643:Phenoxybenzamine / Q000627:therapeutic use; D010673:Pheochromocytoma / Q000188:drug therapy; D011433:Propranolol / Q000627:therapeutic use; D013771:Tetralogy of Fallot / Q000188:drug therapy
D000319:Adrenergic beta-Antagonists; D001337:Autonomic Agents; D008781:Methyltyrosines; D010643:Phenoxybenzamine; D011433:Propranolol; D007545:Isoproterenol; D004837:Epinephrine